Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Knowledge-based automatic plan optimization for left-sided whole breast tomotherapy.
Esposito PG, Castriconi R, Mangili P, Broggi S, Fodor A, Pasetti M, Tudda A, Di Muzio NG, Del Vecchio A, Fiorino C. Esposito PG, et al. Among authors: pasetti m. Phys Imaging Radiat Oncol. 2022 Jun 23;23:54-59. doi: 10.1016/j.phro.2022.06.009. eCollection 2022 Jul. Phys Imaging Radiat Oncol. 2022. PMID: 35814259 Free PMC article.
Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients.
Cozzarini C, Fiorino C, Da Pozzo LF, Alongi F, Berardi G, Bolognesi A, Briganti A, Broggi S, Deli A, Guazzoni G, Perna L, Pasetti M, Salvadori G, Montorsi F, Rigatti P, Di Muzio N. Cozzarini C, et al. Among authors: pasetti m. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):191-9. doi: 10.1016/j.ijrobp.2010.09.027. Epub 2010 Nov 23. Int J Radiat Oncol Biol Phys. 2012. PMID: 21109361
PET-guided dose escalation tomotherapy in malignant pleural mesothelioma.
Fodor A, Fiorino C, Dell'Oca I, Broggi S, Pasetti M, Cattaneo GM, Gianolli L, Calandrino R, Di Muzio NG. Fodor A, et al. Among authors: pasetti m. Strahlenther Onkol. 2011 Nov;187(11):736-43. doi: 10.1007/s00066-011-2234-6. Epub 2011 Oct 28. Strahlenther Onkol. 2011. PMID: 22037650
Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study.
Di Muzio NG, Fodor A, Noris Chiorda B, Broggi S, Mangili P, Valdagni R, Dell'Oca I, Pasetti M, Deantoni CL, Chiara A, Berardi G, Briganti A, Calandrino R, Cozzarini C, Fiorino C. Di Muzio NG, et al. Among authors: pasetti m. Clin Oncol (R Coll Radiol). 2016 Aug;28(8):490-500. doi: 10.1016/j.clon.2016.02.005. Epub 2016 Mar 5. Clin Oncol (R Coll Radiol). 2016. PMID: 26961088 Clinical Trial.
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.
Fodor A, Berardi G, Fiorino C, Picchio M, Busnardo E, Kirienko M, Incerti E, Dell'Oca I, Cozzarini C, Mangili P, Pasetti M, Calandrino R, Gianolli L, Di Muzio NG. Fodor A, et al. Among authors: pasetti m. BJU Int. 2017 Mar;119(3):406-413. doi: 10.1111/bju.13510. Epub 2016 May 24. BJU Int. 2017. PMID: 27104782
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients.
Incerti E, Broggi S, Fodor A, Cuzzocrea M, Samanes Gajate AM, Mapelli P, Fiorino C, Dell'Oca I, Pasetti M, Cattaneo M, Calandrino R, Gianolli L, Di Muzio N, Picchio M. Incerti E, et al. Among authors: pasetti m. Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2071-2078. doi: 10.1007/s00259-018-4056-6. Epub 2018 Jun 6. Eur J Nucl Med Mol Imaging. 2018. PMID: 29876617
Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
Fodor A, Broggi S, Incerti E, Dell'Oca I, Fiorino C, Samanes Gajate AM, Pasetti M, Cattaneo MG, Passoni P, Gianolli L, Calandrino R, Picchio M, Di Muzio N. Fodor A, et al. Among authors: pasetti m. Clin Lung Cancer. 2019 Jan;20(1):e29-e38. doi: 10.1016/j.cllc.2018.08.019. Epub 2018 Sep 3. Clin Lung Cancer. 2019. PMID: 30253920
Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype.
Di Micco R, Zuber V, Fiacco E, Carriero F, Gattuso MI, Nazzaro L, Panizza P, Gianolli L, Canevari C, Di Muzio N, Pasetti M, Sassi I, Zambetti M, Gentilini OD. Di Micco R, et al. Among authors: pasetti m. Eur J Surg Oncol. 2019 Jun;45(6):969-975. doi: 10.1016/j.ejso.2019.01.219. Epub 2019 Jan 31. Eur J Surg Oncol. 2019. PMID: 30744944
Corrigendum to "Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype" [Eur. J. Surg. Oncol. 45, (6) (2019) 969-975].
Di Micco R, Zuber V, Fiacco E, Carriero F, Gattuso MI, Nazzaro L, Panizza P, Gianolli L, Canevari C, Di Muzio N, Pasetti M, Sassi I, Zambetti M, Gentilini OD. Di Micco R, et al. Among authors: pasetti m. Eur J Surg Oncol. 2019 Sep;45(9):1754. doi: 10.1016/j.ejso.2019.07.007. Epub 2019 Jul 13. Eur J Surg Oncol. 2019. PMID: 31307816 No abstract available.
217 results